Psychiatry & Neurology Doctors in Oldbridge, NJ Accepting Medicare
1 Psychiatry & Neurology doctors found. Showing 1 - 1
 Aldonia Swamy, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 400 Perrine Road, Suite 404, Oldbridge, NJ 08857 Phone: 732-727-3723 |
News Archive
New Study Links Passive Smoke to Heart Attacks
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
Study provides new insight on how HER2-low tumors may evolve in breast cancer patients
The finding that breast tumors can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumors.
Seattle Children's Hospital uses IBM Big Data technology to improve treatment of young patients
IBM and Brightlight today announced that Seattle Children's Hospital is using IBM Big Data technology to improve treatment of its young patients. With over 350,000 patient visits annually and thousands of data points associated with each patient, Seattle Children's Hospital can run queries on patient data in seconds, rather than minutes, to provide quicker, more effective care and diagnosis.
Japan's MHLW grants full marketing authorization to REVLIMID
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.
CRISPR tool unlocks potential for novel treatments across different therapeutic areas
CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas.
› Verified 4 days ago